Literature DB >> 28418500

Risk of Uveitis Among People With Psoriasis: A Nationwide Cohort Study.

Ching-Chi Chi1, Tao-Hsin Tung2, Jui Wang3, Yu-Sheng Lin4, Yu-Fen Chen5, Tsui-Kan Hsu6, Shu-Hui Wang7.   

Abstract

Importance: Uveitis has been associated with psoriatic arthritis, but to our knowledge, the relationship between uveitis and psoriasis is unsettled among researchers. Objective: To evaluate the risk of incident uveitis among people with psoriasis. Design, Setting, and Participants: This nationwide, retrospective cohort study conducted in Taiwan from January 1, 2000, to December 31, 2012 included 147 954 people with psoriasis (including 10 107 with concomitant psoriatic arthritis and 137 847 without psoriatic arthritis) and 147 954 nonpsoriatic controls. Exposure: Psoriasis. Main Outcomes and Measures: Risk of incident uveitis.
Results: The mean (SD) age of the 295 908 study participants was 44.4 (19.8) years, and 41.2% (n = 121 878) were women. We found that the group with severe psoriasis with psoriatic arthritis had the greatest risk of incident uveitis compared with the nonpsoriatic controls (adjusted hazard ratio, 2.40; 95% CI, 1.90-3.02). The group with severe psoriasis without psoriatic arthritis and the group with mild psoriasis with psoriatic arthritis also had an increased risk of incident uveitis (adjusted hazard ratio, 1.42; 95% CI, 1.23-1.64; and 1.42; 95% CI, 1.03-1.96; respectively). However, an increased risk for incident uveitis with mild psoriasis without psoriatic arthritis was not identified (adjusted hazard ratio, 1.09; 95% CI, 1.00-1.20). Conclusions and Relevance: People with severe psoriasis and those with mild psoriasis have an increased risk of uveitis. Clinicians may use this finding as a guide for uveitis risk stratification among patients with different inflammatory presentations on the spectrum of psoriatic disease.

Entities:  

Mesh:

Year:  2017        PMID: 28418500      PMCID: PMC5846892          DOI: 10.1001/jamaophthalmol.2017.0569

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  26 in total

1.  The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity.

Authors:  Wolf-Henning Boehncke; Sandra Boehncke; Anne-Marie Tobin; Brian Kirby
Journal:  Exp Dermatol       Date:  2011-04       Impact factor: 3.960

2.  Medical comorbidity associated with psoriasis in adults: a population-based study.

Authors:  Y-W Yang; J J Keller; H-C Lin
Journal:  Br J Dermatol       Date:  2011-09-29       Impact factor: 9.302

3.  Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: A nationwide population-based cohort study.

Authors:  Ching-Chi Chi; Jui Wang; Yu-Fen Chen; Shu-Hui Wang; Fu-Li Chen; Tao-Hsin Tung
Journal:  J Dermatol Sci       Date:  2015-03-30       Impact factor: 4.563

4.  Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study.

Authors:  H-Y Chiu; H-L Huang; C-H Li; Y-J Yin; H-A Chen; S-T Hsu; S-J Lin; T-F Tsai; S-Y Ho
Journal:  Br J Dermatol       Date:  2015-05-12       Impact factor: 9.302

5.  Psoriasis and the eye: prevalence of eye disease in Singaporean Asian patients with psoriasis.

Authors:  Nisha S Chandran; Malcolm Greaves; Fei Gao; Laurence Lim; Bob C L Cheng
Journal:  J Dermatol       Date:  2007-12       Impact factor: 4.005

6.  The risk of stroke in patients with psoriasis.

Authors:  Joel M Gelfand; Erica D Dommasch; Daniel B Shin; Rahat S Azfar; Shanu K Kurd; Xingmei Wang; Andrea B Troxel
Journal:  J Invest Dermatol       Date:  2009-05-21       Impact factor: 8.551

7.  Cost-efficacy of biologic therapies for psoriatic arthritis from the perspective of the Taiwanese healthcare system.

Authors:  Tsong-Shing Yang; Ching-Chi Chi; Shu-Hui Wang; Jing-Chi Lin; Ko-Ming Lin
Journal:  Int J Rheum Dis       Date:  2015-09-25       Impact factor: 2.454

8.  Psoriasis, psoriatic arthritis, or psoriatic disease?

Authors:  Raffaele Scarpa; Fabio Ayala; Nicola Caporaso; Ignazio Olivieri
Journal:  J Rheumatol       Date:  2006-02       Impact factor: 4.666

9.  Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009.

Authors:  Maryam M Asgari; Jashin J Wu; Joel M Gelfand; Craig Salman; Jeffrey R Curtis; Leslie R Harrold; Lisa J Herrinton
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-05-02       Impact factor: 2.890

10.  Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study.

Authors:  Joy Wan; Shuwei Wang; Kevin Haynes; Michelle R Denburg; Daniel B Shin; Joel M Gelfand
Journal:  BMJ       Date:  2013-10-15
View more
  23 in total

1.  Association of Psoriasis With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

Authors:  Yun Fu; Cheng-Han Lee; Ching-Chi Chi
Journal:  JAMA Dermatol       Date:  2018-12-01       Impact factor: 10.282

Review 2.  Identifying and Treating Ocular Manifestations in Psoriasis.

Authors:  Mahsaw Motlagh; Christopher Fortenbach; Howard I Maibach; Bobeck S Modjtahedi
Journal:  Am J Clin Dermatol       Date:  2021-11-03       Impact factor: 7.403

Review 3.  Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review.

Authors:  Jin Bu; Ruilian Ding; Liangjia Zhou; Xiangming Chen; Erxia Shen
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

4.  Association between uveitis and psoriatic disease: a systematic review and Meta-analysis based on the evidence from cohort studies.

Authors:  Chao-Ran Li; Lang Chen; Long-Fei Wang; Bin Yan; You-Ling Liang; Jing Luo
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

5.  Lifestyle changes for treating psoriasis.

Authors:  Shu-Hua Ko; Ching-Chi Chi; Mei-Ling Yeh; Shu-Hui Wang; Yu-Shiun Tsai; Mei-Ya Hsu
Journal:  Cochrane Database Syst Rev       Date:  2019-07-16

6.  Risk of herpes zoster in psoriasis patients receiving systemic therapies: a nationwide population-based cohort study.

Authors:  Sze-Wen Ting; Sze-Ya Ting; Yu-Sheng Lin; Ming-Shyan Lin; George Kuo
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

Review 7.  Psoriasis and uveitis.

Authors:  Büşra Köse; Dilek Uzlu; Hidayet Erdöl
Journal:  Int Ophthalmol       Date:  2022-01-19       Impact factor: 2.029

8.  Association of Benzodiazepine Receptor Agonist Use With Changes in Psoriasis Severity in Adult Population: A Population-Based Study.

Authors:  Ke-Ting Pan; I-Hsun Li; Hui-Han Kao; Yi-Hsien Chen; Pei-Xun Zhong; Li-Ting Kao
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

9.  Risk of inflammatory bowel disease in uveitis patients: a population-based cohort study.

Authors:  Tzu-Chen Lo; Yu-Yen Chen; Hsin-Hua Chen
Journal:  Eye (Lond)       Date:  2021-06-21       Impact factor: 4.456

10.  Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study.

Authors:  Karin Bengtsson; Helena Forsblad-d'Elia; Anna Deminger; Eva Klingberg; Mats Dehlin; Sofia Exarchou; Ulf Lindström; Johan Askling; Lennart T H Jacobsson
Journal:  Rheumatology (Oxford)       Date:  2021-06-18       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.